Transform CV Risk in Diabetes (CVRiD)
Type 2 Diabetes
About this trial
This is an interventional treatment trial for Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria: T2D diagnosis in the medical record ASCVD, defined as follows: Known Coronary artery disease (CAD), prior Acute coronary syndrome (ACS), or coronary artery revascularization Prior TIA/ischemic stroke or known carotid or intracerebral atherosclerosis, or prior carotid revascularization Prior Peripheral artery disease (PAD) including symptomatic claudication or pe-ripheral revascularization Exclusion Criteria: Current participation in an interventional clinical assessment of an investigational drug/device (excluding assessments related to COVID-19) Currently receiving any SGLT2i or GLP-1RA Known allergy/hypersensitivity/intolerance/contraindication to SGLT2i or GLP-1RA Currently receiving comfort care or enrolled in hospice Life expectancy <1 year History of or plan for heart transplantation or ventricular assist device Current or planned hemodialysis Decompensated end stage liver disease History of Fournier's Gangrene Type 1 diabetes Prior history of diabetic ketoacidosis Pregnancy or active breastfeeding History of Pancreatitis or pancreatic cancer History of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN-2)
Sites / Locations
- Multiple sites nationwideRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Active Comparator
Active Comparator
Education alone
Education + decision support to provide suggestions for care optimization
Education + facilitated referral to cardiometabolic team-based center for care optimization